← SynDRA
GW843682X
SynDRA canonical compound SYN0014333 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLK1 |
|---|
| Mechanism of action | PLK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- PAK1
- PAK3
- PAK4
- PAK5
- PAK6
- PASK
- PBK
- PDGFRA
- PDGFRB
- PDK1
- PDPK1
- PHKG1
- PHKG2
- PI4KB
- PIK3CA
- PIK3CD
- PIM1
- PIM2
- PIM3
- PIP4K2B
- PIP5K1C
- PKN2
- PLK2
- PLK4
- PRKAA1
- PRKAA2
- PRKACA
- PRKCA
- PAK2
- OGG1
- PRKCG
- NUAK1
- MAPKAPK3
- MAPKAPK5
- MARK1
- MARK2
- MARK3
- MARK4
- MBD4
Cross-references
Synonyms
- GW-843682X
- RefChem:783291
- GW843682
- C22H18F3N3O4S
- Kinome_3462
- thiophene deriv., 20
- MLS006010260
- BMCL191018 Compound 2
- orb1308238
- SCHEMBL1286884
- SCHEMBL29432471
- SCHEMBL31416068
- BDBM25120
- CHEBI:91334
- GLXC-07608
- HMS3265C07
- HMS3265C08
- HMS3265D07
- HMS3265D08
- HMS3267H10
- HMS3303O23
- HMS3305I14
- HMS3413H06
- HMS3677H06
- EX-A7699
- MFCD09971143
- NSC756404
- AKOS022178986
- CS-0070
- EBC-521821
- GW843682X?
- NSC-756404
- SDCCGGSK-0000191.P001
- NCGC00242217-01
- NCGC00242217-02
- NCGC00242217-04
- NCGC00242217-05
- HY-11003
- MS-28855
Look up GW843682X in the interactive SynDRA portal →